Works matching IS 10233830 AND DT 2009 AND VI 58 AND IP 4

Results: 8

Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 184, doi. 10.1007/s00011-008-8118-2

By:

S.-J. Lee;
K.-T. Lim

Publication type:

Article

Induction of muscle weakness by local inflammation: an experimental animal model.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 175, doi. 10.1007/s00011-008-8093-7

By:

S. Bicer;
P. Reiser;
S. Ching;
N. Quan

Publication type:

Article

Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 192, doi. 10.1007/s00011-008-8120-8

By:

N. Yamaguchi;
H. Isomoto;
H. Mukae;
H. Ishimoto;
K. Ohnita;
S. Shikuwa;
Y. Mizuta;
M. Nakazato;
S. Kohno

Publication type:

Article

3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti- Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 218, doi. 10.1007/s00011-008-8139-x

By:

R. Marrakchi;
K. Bougatef;
A. Moussa;
S. Ouerhani;
H. Khodjet-el-Khil;
Y. Messai;
O. Mestiri;
T. Najar;
A. Benammar-Elgaaeid

Publication type:

Article

Enhancement of activated β1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 224, doi. 10.1007/s00011-008-8138-y

By:

M. Kajimoto;
T. Ichiyama;
Y. Ueno;
M. Shiraishi;
M. Hasegawa;
S. Furukawa

Publication type:

Article

Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 210

By:

E. Aragão;
L. Chioato;
T. Ferreira;
A. de Medeiros;
A. Secatto;
L. Faccioli;
R. Ward

Publication type:

Article

Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 198, doi. 10.1007/s00011-008-8131-5

By:

S. Hagiwara;
H. Iwasaka;
S. Hidaka;
A. Hasegawa;
T. Noguchi

Publication type:

Article

A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5.

Published in:

Inflammation Research, 2009, v. 58, n. 4, p. 204, doi. 10.1007/s00011-008-8132-4

By:

M. Amano;
A. Carneiro;
O. Ribeiro;
W. Cabrera;
M. De Franco;
O. Ibañez;
L. Isaac;
N. Starobinas

Publication type:

Article

Works matching IS 10233830 AND DT 2009 AND VI 58 AND IP 4

Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells.

Induction of muscle weakness by local inflammation: an experimental animal model.

Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease.

3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti- Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population.

Enhancement of activated β<sub>1</sub>-integrin expression by prostaglandin E<sub>2</sub> via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.

Suramin inhibits macrophage activation by human group IIA phospholipase A<sub>2</sub>, but does not affect bactericidal activity of the enzyme.

Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB.

A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5.